Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors

被引:11
|
作者
Szabo, Monika [1 ]
Lim, Herman D. [1 ]
Herenbrink, Carmen Klein [1 ]
Christopoulos, Arthur [1 ]
Lane, J. Robert [1 ]
Capuano, Ben [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
ALLOSTERIC MODULATORS; AGONIST; DRUGS; ANTIPSYCHOTICS; DISCOVERY; MODES; LEAD;
D O I
10.1021/jm5013243
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.
引用
收藏
页码:1550 / 1555
页数:6
相关论文
共 50 条
  • [1] Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
    Albizu, Laura
    Holloway, Terrell
    Gonzalez-Maeso, Javier
    Sealfon, Stuart C.
    NEUROPHARMACOLOGY, 2011, 61 (04) : 770 - 777
  • [2] Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
    Lukasiewicz, Sylwia
    Polit, Agnieszka
    Kendracka-Krok, Sylwia
    Wedzony, Krzysztof
    Mackowiak, Marzena
    Dziedzicka-Wasylewska, Marta
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12): : 1347 - 1358
  • [3] REELIN INFLUENCES THE EXPRESSION AND FUNCTION OF DOPAMINE D2 AND SEROTONIN 5-HT2A RECEPTORS: A COMPARATIVE STUDY
    Varela, M. J.
    Lage, S.
    Caruncho, H. J.
    Cadavid, M. I.
    Loza, M. I.
    Brea, J.
    NEUROSCIENCE, 2015, 290 : 165 - 174
  • [4] New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors
    Fernández, F
    García-Mera, X
    Rodríguez, G
    Urrutia, A
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 1006 - 1009
  • [5] Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain
    Ishii, Tatsuya
    Kimura, Yasuyuki
    Ichise, Masanori
    Takahata, Keisuke
    Kitamura, Soichiro
    Moriguchi, Sho
    Kubota, Manabu
    Zhang, Ming-Rong
    Yamada, Makiko
    Higuchi, Makoto
    Okubo, Yoshinori
    Suhara, Tetsuya
    PLOS ONE, 2017, 12 (12):
  • [6] Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors
    Butini, Stefania
    Campiani, Giuseppe
    Franceschini, Silvia
    Trotta, Francesco
    Kumar, Vinod
    Guarino, Egeria
    Borrelli, Giuseppe
    Fiorini, Isabella
    Novellino, Ettore
    Fattorusso, Caterina
    Persico, Marco
    Orteca, Nausicaa
    Sandager-Nielsen, Karin
    Jacobsen, Thomas Amos
    Madsen, Kim
    Scheel-Kruger, Jorgen
    Gemma, Sandra
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4803 - 4807
  • [7] Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex
    Szlachta, Marta
    Kusmider, Maciej
    Pabian, Paulina
    Solich, Joanna
    Kolasa, Magdalena
    Zurawek, Dariusz
    Dziedzicka-Wasylewska, Marta
    Faron-Gorecka, Agata
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [8] Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents
    Ye, Na
    Song, Zilan
    Zhang, Ao
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (04) : 437 - 457
  • [9] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Ragy R. Girgis
    Andy Forbes
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2020, 45 : 786 - 792
  • [10] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792